• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS HBSAG REAGENT PACK; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS HBSAG REAGENT PACK; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6801322
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/11/2019
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that lower than expected, (b)(6) vitros hepatitis b surface antigen (hbsag) results were attained from a non-vitros biorad virotrol i (b)(6) control fluid using vitros immunodiagnostic products hbsag reagent lot 8561 on a vitros xt7600 integrated system.The assignable cause of the event was not established.An issue with the biorad virotrol i quality control fluid cannot be ruled out as a contributor to the event as there were no issues with vitros or other non-vitros quality control results when tested using vitros hbsag reagent lot 8561.Additionally, user error cannot be ruled out as a contributor to the event.It is possible that the customer was using an expired quality control fluid, not handling the quality control fluid correctly or not running the intended class of biorad quality control fluids although this could not be confirmed.The lower than expected vitros hbsag result of (b)(6) was likely due to fluid mix up, the fluid tested was most likely the biorad viroclear quality control fluid, however, this was not confirmed.An issue with vitros hbsag lot 8561 is an unlikely contributor to the event, as vitros hbsag quality control results for other fluids were within acceptable guidelines.Additionally, ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros hbsag lot 8561.There was no evidence to suggest an instrument malfunction contributed to the event.However, as no precision testing was conducted on the vitros xt 7600 integrated system around the time of the event, an instrument issue cannot be entirely ruled out as a contributor to the event.
 
Event Description
A customer reported (b)(6) vitros hepatitis b surface antigen (hbsag) results obtained from a non-vitros (biorad) (b)(6) control fluid using vitros immunodiagnostic products hbsag reagent on a vitros xt7600 integrated system.Biorad virotrol i quality control results of (b)(6).Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The (b)(6) vitros hbsag results were obtained from a non-patient quality control fluid.The customer did not give any indication that patient results had been affected.However, the investigation cannot conclude that patient sample results would not be affected if the event were to recur undetected.There have been no allegations of patient harm as a result of this event.This report is number 3 of 4 mdr¿s for this event.Four (4) 3500a forms are being submitted for this event as 4 devices were involved.This report corresponds to ortho clinical diagnostics inc.Complaint numbers (b)(4).
 
Event Description
Four supplemental emdr created to correct the date of event in the following trackwise records: emdr (b)(4) (3007111389-2020-00004), emdr (b)(4) (3007111389-2020-00005), emdr (b)(4) (3007111389-2020-00006), and emdr (b)(4) (3007111389-2020-00007).The above emdrs were sent to the fda on 10 january 2020.The date of event was erroneously entered as (b)(6) 2020 in field b3 of the emdrs.The correct date of the event is (b)(6) 2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS HBSAG REAGENT PACK
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
MDR Report Key9575248
MDR Text Key223664434
Report Number3007111389-2020-00006
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 12/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/08/2020
Device Catalogue Number6801322
Device Lot Number8561
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 12/12/2019
Initial Date FDA Received01/10/2020
Supplement Dates Manufacturer Received12/12/2019
Supplement Dates FDA Received12/02/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-